Trial of Imatinib for Hospitalized Adults With COVID-19

Stopped The Principal Investigator left the institution. The study was halted prematurely.

Conditions

• COVID-19

Interventions

• DRUG: Imatinib
• DRUG: Placebo oral tablet

Sponsor

University of Maryland, Baltimore